AC Immune SA (ACIU)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$2.92

Buy

$2.94

arrow-down$-0.35 (-10.64%)

Prices updated at 17 Dec 2025, 23:42 EST

Prices minimum 15 mins delay

Prices in USD

AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.

NASDAQ

-1.81%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$3.32 - $2.90
	$4.00 - $1.43
	-
	331.98m
	-
	-
	526,645
	4.23
	288,062.90
	3.63
	111.31m
	CH0329023102
	-0.72
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.